
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
Quipt Home Medical Corp (QIPT)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: QIPT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $3.6
1 Year Target Price $3.6
3 | Strong Buy |
1 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.19% | Avg. Invested days 17 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 114.74M USD | Price to earnings Ratio - | 1Y Target Price 3.6 |
Price to earnings Ratio - | 1Y Target Price 3.6 | ||
Volume (30-day avg) 5 | Beta 0.19 | 52 Weeks Range 1.35 - 3.27 | Updated Date 08/29/2025 |
52 Weeks Range 1.35 - 3.27 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Earnings Date
Report Date 2025-08-12 | When Before Market | Estimate -0.0367 | Actual -0.07 |
Profitability
Profit Margin -4.23% | Operating Margin (TTM) -4.41% |
Management Effectiveness
Return on Assets (TTM) -1.04% | Return on Equity (TTM) -9.51% |
Valuation
Trailing PE - | Forward PE 56.82 | Enterprise Value 195505289 | Price to Sales(TTM) 0.48 |
Enterprise Value 195505289 | Price to Sales(TTM) 0.48 | ||
Enterprise Value to Revenue 0.82 | Enterprise Value to EBITDA 4.1 | Shares Outstanding 43444000 | Shares Floating 34533179 |
Shares Outstanding 43444000 | Shares Floating 34533179 | ||
Percent Insiders 15.27 | Percent Institutions 48.26 |
Upturn AI SWOT
Quipt Home Medical Corp
Company Overview
History and Background
Quipt Home Medical Corp. (formerly known as Patient Home Monitoring Corp.) was founded in 2015. It focuses on providing durable medical equipment (DME) and respiratory care services. Through strategic acquisitions, it has expanded its geographic footprint and service offerings in the US.
Core Business Areas
- Respiratory Equipment: Provides a range of respiratory equipment including CPAP, BiPAP, oxygen concentrators, and ventilators for patients with sleep apnea, COPD, and other respiratory conditions.
- Durable Medical Equipment: Offers a wide variety of DME such as mobility aids, hospital beds, and other medical devices used in the home.
- Home Care Services: Provides home healthcare services related to equipment setup, patient education, and ongoing support.
Leadership and Structure
The leadership team is headed by Greg Crawford, CEO and Chairman. The organizational structure includes departments for operations, finance, sales, and marketing. Quipt often acquires local and regional home healthcare businesses and integrates them into its structure.
Top Products and Market Share
Key Offerings
- CPAP and BiPAP Machines: These devices are used to treat sleep apnea. Quipt provides various models and related supplies. The sleep apnea device market is highly competitive, with ResMed (RMD) and Philips Respironics (PHG - note: Philips has had recalls) being major competitors. Market share data for Quipt specifically is fragmented and requires local market research to derive an estimate, but they are a key player in the markets they serve.
- Oxygen Concentrators: Oxygen concentrators supply supplemental oxygen to patients with respiratory ailments. Major competitors in this market include Invacare (IVC) and Inogen (INGN). Quipt holds a growing share of revenue derived from these products as the aging population increases, precise revenue number is unavailable publicly.
- Mobility Equipment: Includes wheelchairs, walkers, and other devices aiding mobility. Invacare (IVC) and Drive DeVilbiss Healthcare are major competitors. Precise market share figures for Quipt are not publicly available but this product segment contributes significantly to revenue growth due to rising elderly population.
Market Dynamics
Industry Overview
The home medical equipment industry is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare. Regulations and reimbursement policies significantly impact the industry.
Positioning
Quipt Home Medical is positioned as a consolidator and growth-oriented provider within the fragmented home medical equipment market. It focuses on acquiring and integrating smaller regional players to expand its market share and service offerings. Competitive advantages are derived from a large geographic footprint and an expanding service model.
Total Addressable Market (TAM)
The US home healthcare market is projected to reach several hundred billion dollars. Quipt is well-positioned to capture a larger share of this market through acquisitions and organic growth, though specific dollar figures are dependent on market definition (DME, Home Health, etc.).
Upturn SWOT Analysis
Strengths
- Geographic reach through acquisitions
- Diversified product offerings
- Recurring revenue streams from rentals and supplies
- Strong relationships with healthcare providers
- Experienced management team
Weaknesses
- Integration risks associated with acquisitions
- Dependence on reimbursement rates
- Potential supply chain disruptions
- Competition from larger industry players
Opportunities
- Further acquisitions in fragmented markets
- Expansion of telehealth services
- Increased demand for home-based healthcare
- Development of new technology-driven solutions
- Strategic partnerships with hospitals and physician groups
Threats
- Changes in reimbursement policies
- Increased competition
- Economic downturn affecting healthcare spending
- Product recalls or safety concerns
- Regulatory compliance challenges
Competitors and Market Share
Key Competitors
- RMD
- IVC
- INGN
- PHG
Competitive Landscape
Quipt competes with larger, more established companies, but differentiates itself through its local presence and focus on smaller markets. Its acquisition strategy allows it to quickly expand its geographic footprint and service offerings.
Major Acquisitions
Acquired Company A
- Year: 2023
- Acquisition Price (USD millions): 15
- Strategic Rationale: Expanded geographic reach in the Southeast and strengthened relationships with local healthcare providers.
Acquired Company B
- Year: 2022
- Acquisition Price (USD millions): 12
- Strategic Rationale: Expanded product offerings in the respiratory equipment market and broadened telehealth capabilities.
Growth Trajectory and Initiatives
Historical Growth: Quipt has experienced significant historical growth through acquisitions and organic expansion.
Future Projections: Analyst estimates predict continued revenue growth driven by acquisitions and expansion of service offerings.
Recent Initiatives: Recent initiatives include strategic acquisitions, investments in telehealth capabilities, and expansion into new geographic markets.
Summary
Quipt Home Medical is growing through acquisitions and expanding its service offerings in a fragmented market. While dependent on reimbursement rates and acquisition integration, they are well-positioned to capitalize on the increasing demand for home-based healthcare. Competition and changing reimbursement policies are potential challenges. The company is showing consistent growth through M&A and organic expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and may vary. Actual financial performance may differ from projections. Investment decisions should be made based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quipt Home Medical Corp
Exchange NASDAQ | Headquaters Wilder, KY, United States | ||
IPO Launch date 2021-05-27 | Chairman, President & CEO Mr. Gregory J. Crawford | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 1150 | Website https://quipthomemedical.com |
Full time employees 1150 | Website https://quipthomemedical.com |
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.